Is Prophylactic Antibiotics Necessary In Otherwise Healthy Adult Patients Undergoing Ureteroscopic Procedures for Ureteral Stones?
1 other identifier
observational
52
1 country
1
Brief Summary
The present study aims to investigate the relative efficacy, safety and risk of a single-dose prophylaxis in otherwise healthy adult patients undergoing ureteroscopic procedures for ureteral stones.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 6, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedFirst Posted
Study publicly available on registry
December 18, 2015
CompletedDecember 18, 2015
December 1, 2015
1.9 years
August 6, 2014
December 16, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evidence of clinically definite urinary tract infection confirmed by urinary analysis or urinary culture.
within the first 10 days (plus or minus 5 days) after surgery
Study Arms (1)
prophylactic antibiotics
Eligibility Criteria
Cohort study
You may qualify if:
- otherwise healthy adult patients.
- Aged from 20 to 65 years.
- Undergoing ureteroscopic procedures for ureteral stones.
You may not qualify if:
- Have the urine road the infection before the surgical operation, the surgical operation once took antibiotics the first 2 week.
- Pregnant or the women been breast feeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cheng-Hsing Hsieh
Taipei, Xindian, 23142, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director,Department of Urology
Study Record Dates
First Submitted
August 6, 2014
First Posted
December 18, 2015
Study Start
April 1, 2013
Primary Completion
March 1, 2015
Study Completion
March 1, 2015
Last Updated
December 18, 2015
Record last verified: 2015-12